Journal of Multiple Sclerosis

ISSN - 2376-0389
NLM - 101654564

Bianca Weinstock-Guttman

Bianca Weinstock-Guttman
Executive Editor
Professor, Department of Neurology
University at Buffalo, USA


Bianca Weinstock-Guttman, MD, is Professor of Neurology at the State University of New York at Buffalo, and Director of the Jacobs Multiple Sclerosis Center for Treatment and Research at UBMD Neurology. She is also the Director of the Pediatric Multiple Sclerosis Center of Buffalo, one of six centers of excellence established by the National Multiple Sclerosis Society. In addition, she also serves as Executive Director of the New York State Multiple Sclerosis Consortium (NYSMSC). Dr. Weinstock-Guttman has been involved in multiple pivotal therapeutic clinical trials in MS and currently is involved in multiple phase III studies as well as in investigator-initiated phase I and IV studies.  She has published more than 240 peer-reviewed articles in main Neurology and Immunology journals.  She has also given several hundred poster presentations and is frequently invited as a guest lecturer to national and international conferences.  Her current research interests are in better understanding the heterogeneity of MS, identifying predictors of disease progression with a primary focus on genetic and environmental interactions and influences on MS disease phenotype, and response to therapy and influences on physical and neurocognitive status.  Pediatric MS, a new and insufficiently explored subject, is an important area of her clinical and research interest as part of a well-established national network.  Dietary supplementation and modification as well as the vascular theory of MS and influence on the pathobiology of MS also represent a more recent focus of Dr. Weinstock-Guttman’s research. Research funding is received from various agencies including but not limited to the National Institutes of Health, Department of Defense, National Multiple Sclerosis Society, NSF as well as the pharmaceutical industry.

Research Interest

Clinical trials in MS, pediatric MS, genetic and environmental interactions and influences on MS disease phenotype